Business Practice

The pharmaceutical industry receives its fair share of both praise and scorn. Behind the politics, the hard work and impressive achievements of legions of industry researchers often go unnoticed.

Sir Andrew Witty seeks to cement his legacy as GSK addresses patents and medicines access in the developing world

A newly introduced tax law in the US puts an end to the would-be mega-merger between Pfizer and Allergan

The Power List is back, but is it a fair representation of the male to female ratio in our industry?

This application note explores the use of the Morphologi G3-ID for Morphologically-Directed Raman spectroscopy (MDRS) to identify and analyze contaminants including protein aggregates present in a stressed sample of lysozyme, and to compare particles held in suspension within a thin path wet cell with those collected on a filter membrane.

Work performed in conjunction with Spiber Technologies, Uppsala, Sweden. Use of dynamic and electrophoretic light scattering to assess the effects of protein formulation composition

Sitting Down With... Keith Thompson, CEO of the Cell and Gene Therapy Catapult, UK.

Statisticians are vital in the pharma industry, but rarely do they receive public fanfare for their work. The Award for Statistical Excellence in the Pharmaceutical Industry aims to change the status quo.

Pharma companies are notoriously protective of their intellectual property, so it’s a big deal to open up and give knowledge away for free. Nevertheless, it is the path that LEO Pharma took with its Open Innovation platform – and they’ve learnt that, if you give a little away, you can expect much in return.

A new study estimates that 11.6 billion euros’ worth of goods are being stolen across Europe each year – but what about pharmaceuticals?